CD8A and influenza: Live attenuated influenza vaccines (LAIVs) consistently induce robust TRMs in respiratory mucosa, with intranasal LAIV administration generating lung CD8+ TRMs in ferrets and pigs that persist for more than 3 months and mediate cross-strain protection independent of circulating antibodies [233].